Origen de la red de primer grado Christina Brattström.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Biotechnology | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Christina Brattström a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Stockholm | College/University | Masters Business Admin | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Warwick | College/University | Doctorate Degree | |
| University of South Australia | College/University | Undergraduate Degree | |
| University of Lund | College/University | Doctorate Degree | |
| University of Leiden | College/University | Graduate Degree | |
| University of Utrecht | College/University | Doctorate Degree | |
| University of Surrey | College/University | Undergraduate Degree | |
| MIDSONA AB | Pharmaceuticals: Other | Director of Finance/CFO | |
| University of Kalmar | College/University | Graduate Degree | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Corporate Officer/Principal | |
Janssen Biologics BV
 Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Janssen Biologics BV manufactures, acquires and markets biopharmaceutical therapies. The firms products focus on cardiovascular and immunological disorders, and cancer. The company was founded in 1984 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MENDUS AB | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Corporate Officer/Principal | |
| Rotterdam University of Applied Sciences | College/University | Undergraduate Degree | |
| ELICERA THERAPEUTICS AB | Biotechnology | Director/Board Member Director/Board Member | |
| Centre For Advanced Medical Products | Director/Board Member | ||
| Capio St Gorans Hospital | Corporate Officer/Principal |
Estadísticas
Internacional
| Suecia | 12 |
| Países Bajos | 6 |
| Reino Unido | 3 |
| Suiza | 2 |
| Australia | 2 |
Sectorial
| Consumer Services | 11 |
| Health Technology | 9 |
Operativa
| Corporate Officer/Principal | 9 |
| Director/Board Member | 6 |
| Doctorate Degree | 5 |
| Independent Dir/Board Member | 3 |
| Undergraduate Degree | 3 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Christina Brattström
- Conexiones Empresas
